Amrita Kamath, Ph.D.

Executive Director and Distinguished Scientist
Genentech, Inc.

Poster(s):

• (M1130-02-10) Bivariate Statistical Analyses Reveal the Performance of Human FcRn Transgenic Mouse in Predicting Human Pharmacokinetics of Therapeutic Antibodies
  Monday, October 21, 2024

  11:30 AM – 12:30 PM MT

• (M1530-02-12) Characterizing Interactions of RO7297089, an Anti-B-Cell Maturation Antigen (BCMA)/CD16A Bispecific Tetravalent Antibody with Shed Soluble CD16A Antigen in Plasma In Vitro
  Monday, October 21, 2024

  3:30 PM – 4:30 PM MT